Akums Drugs & Pharma

Akums Drugs And Pharmaceuticals has formed a new subsidiary named 'Akums Healthcare Malta Private Limited' in Malta. The company obtained the registration certificate for this subsidiary on October 20, 2025.

Akums Drugs and Pharmaceuticals Limited has incorporated a joint venture company named Akums Healthcare (Zambia) Private Limited in Zambia. The certificate of incorporation is dated October 13, 2025. This follows previous disclosures made by the company on October 18, 2024 and August 22, 2025.

Akums Drugs and Pharmaceuticals Limited executed a Framework Agreement with the Government of the Republic of Zambia on August 22, 2025, to establish a local manufacturing facility in Zambia. The project will be implemented through a joint venture company where Akums will hold a 51% majority stake and a Zambian state instrumentality will own 49%. The facility is expected to commence manufacturing in 2028, producing general oral solids, liquids, injectables, and beta-lactam products. Until the facility becomes operational, the Government of Zambia will purchase medicines worth a minimum of USD 50 million over two years (2026-2027) at USD 25 million annually from Akums' facilities in India. The joint venture is expected to be established before year-end 2025. The facility aims to support Zambian national health programs, enhance local production capabilities, and potentially export to neighboring African countries including Zimbabwe, Namibia, Botswana, Malawi, Tanzania, and Mozambique. Akums will provide proprietary technology, know-how, and technical expertise through a separate Technology Transfer Agreement.